Final Decision on the Foundation Grant Program

When CIHR created the Foundation Grant program, it was with the intent to support health researchers across all four pillars who were highly successful in the open grants programs. The goal was to support them in a way that would allow them to have the flexibility to pursue new and innovative lines of inquiry, while also training and mentoring the…
Read More
Two internationally recognized researchers join the University of British Columbia as Canada Excellence Research Chairs, bringing international talent in the fields of forest bioproducts and precision cancer drug design. Orlando Rojas has accepted the Canada Excellence Research Chair in Forest Bioproducts, while Sriram Subramaniam will hold the Gobind Khorana Canada Excellence Research Chair in Precision Cancer Drug Design—named after late Nobel Prize-winning UBC biochemistry…
Read More
Nancy Harrison, Chair, LifeSciences BC Board of Directors, announced today the appointment of Wendy Hurlburt, as the organization’s new President and CEO. “We are very pleased to have Wendy join and lead our team; as she brings a strong business background in pharmaceutical, not-for-profit and operations management to this executive position. This is an exciting time for our sector and…
Read More
SFU PhD candidate Careesa Liu’s research focuses on relatively small areas of the brain, but her view of science and technology is much bigger. A biomedical engineer, Liu is completing her PhD at the NeuroTech and ImageTech Labs, both clinically embedded core SFU research facilities near the Surrey campus. She is also working to turn young students from Surrey and…
Read More
The spliceosome has been implicated in genome maintenance for decades. Recently, a surge in discoveries in cancer has suggested that the oncogenic mechanism of spliceosomal defects may involve defective genome stability. The action of the core spliceosome prevents R-loop accumulation, and regulates the expression of genome stability factors. At the same time, specific spliceosomal components have non-canonical functions in genome…
Read More
​These findings are the result of the world’s first randomized clinical trial of SABR as it relates to cancer that has already spread to other parts of the body. The study, led at BC Cancer by Dr. Robert Olson, along with an international team of researchers was recently published in The Lancet. SABR technology is a highly precise form of radiotherapy…
Read More
Academics are often billed as top-notch problem solvers; however, the task of translating their work into policy is a challenge that can leave even the best researchers stumped. What can scientists do to influence policy that supports strong Canadian science and innovation? How does an academic get scientific evidence into the hands of decision makers? These questions and more were…
Read More
This the most detailed study to date describing differences between human genomes. The findings are astounding: an average of 818,054 small insertions and deletions (genomic alterations that each affected less than 50 bases of DNA) and 27,622 SVs (genomic alterations that affected 50 bases or more of DNA) were identified per genome. Remarkably, an average of 156 polymorphic inversions were identified per...
Read More
Inspired by the legacy of Terry Fox, today the Terry Fox Research Institute and partners launched a new national network to bring together, for the first time, leading cancer hospitals and research universities across Canada to accelerate precision medicine for cancer patients. The Marathon of Hope Cancer Centres network is named in honour of Terry’s journey to raise funds for…
Read More